Biogen, Inc. (BIIB)
164.42
-4.15
(-2.46%)
USD |
NASDAQ |
Jan 16, 16:00
163.48
-0.94
(-0.57%)
Pre-Market: 08:26
Biogen Accounts Receivable (Quarterly): 1.85B for Sept. 30, 2025
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Eli Lilly & Co. | 16.11B |
| AbbVie, Inc. | 12.77B |
| Stoke Therapeutics, Inc. | 9.248M |
| Alnylam Pharmaceuticals, Inc. | 964.77M |
| Insmed, Inc. | 65.26M |